Meningioma and radiotherapy

Journal of Neurosurgery

Volumn 117, Issue 4, 2012, Pages 666-668

  Ngwenya, Laura B ^a   Antonio Chiocca, E ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; HISTOPATHOLOGY; HUMAN; MENINGIOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RECURRENCE RISK; REVIEW; TUMOR RECURRENCE; CANCER REGISTRY; FEMALE; MALE; NOTE;

FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; SEER PROGRAM;

EID: 84868369106     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.2.JNS12182     Document Type: Review

References (14)

1. Adamo MB, Johnson CH, Ruhl JL, Dickie LA (eds): 2011 SEER Program Coding and Staging Manual. Bethesda, MD: National Cancer Institute, 2011
2. Adeberg S, Hartmann C, Welzel T, Rieken S, Habermehl D, Von Deimling A, et al: Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas-clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. Int J Radiat Oncol Biol Phys 83:859-864, 2012
3. Aghi M, Carter B, Cosgrove G, Ojemann R, Amin-Hanjani S, Martuza R, et al: Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56-60, 2009
4. Cahill K, Claus E: Treatment and survival of patients with nonmalignant intracranial meningioma: results from the Surveillance, Epidemiology, and End Results program of the National Cancer Institute. Clinical article. J Neurosurg 115:259-267, 2011
5. Combs S, Schulz-Ertner D, Debus J, Von Deimling A, Hartmann C: Improved correlation of the neuropathologic classification according to adapted World Health Organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. Int J Radiat Oncol Biol Phys 81:1415-1421, 2011
6. Jo K, Park H, Nam D, Lee J, Kong D, Park K, et al: Treatment of atypical meningioma. J Clin Neurosci 17:1362-1366, 2010
7. Lal A, Lal D: Limitations of the SEER database for demonstrating causal relationships between treatments and outcomes in pediatric intestinal tumors. J Surg Res 161:237-239, 2010
8. Mair R, Morris K, Scott I, Carroll T: Radiotherapy for atypical meningiomas. Clinical article. J Neurosurg 115:811-819, 2011
9. Nathan H, Pawlik T: Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 15:415-423, 2008
10. National Cancer Institute: SEER-Surveillance, Epidemiology, and End Results Program Brochure. Bethesda, MD: National Cancer Institute, 2012 [http://seer.cancer.gov/about/factsheets/SEER-brochure.pdf] (Accessed July 13, 2012)
11. Perry A, Louis DN, Scheithauer BW, Budka H, Von Deimling A: Meningiomas, in Louis DN, Ohgaki H, Wiestler OD, et al (eds): WHO Classification of Tumours of the Central Nervous System. Lyon: IARC Press, 2007, pp 164-172
12. Rosenberg L, Prayson R, Lee J, Reddy C, Chao S, Barnett G, et al: Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution. Int J Radiat Oncol Biol Phys 74:427-432, 2009
13. Sampson JH, Herndon JE II, Friedman AH, Abernethy AP: Editorial. Epidemiology. J Neurosurg 115:256-258, 2011
14. Stessin AM, Schwartz A, Judanin G, Pannullo SC, Boockvar JA, Schwartz TH, et al: Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis. Clinical article. J Neurosurg [epub ahead of print August 17, 2012. DOI: 10.3171/2012.7. JNS111439]